Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...

An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...

Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...

One, an integrated platform combining high-throughput ADME testing with AI-powered human pharmacokinetic projections.

German researchers have used cerebral organoids to investigate how the epilepsy medication valproate interferes with early ...

Researchers have identified metabolic vulnerabilities in Fibrolamellar cancer, a rare liver malignancy affecting adolescents and young adults, using functional profiling and mass spectrometry. The ...

A novel 3D-printed confined culture system has enabled researchers to generate larger, more advanced human gastrointestinal ...

Tau tangles are a hallmark of Alzheimer's disease and related disorders, but evidence suggests the real damage may come from ...

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...

Researchers at Phenomix Sciences are using machine learning and genetic risk scoring to investigate emotional hunger, an obesity phenotype linked to emotional and reward-driven eating behaviours. Dr ...

Marc Aurel Busche is Professor of Dementia and Neurodegeneration at the University of Basel, where he directs the Memory ...

Dr Thomas Clozel leads Owkin as CEO. He is a former Assistant Professor of Clinical Onco-haematology at Hopital Henri Mondor ...